{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:19:32Z","timestamp":1788445172969,"version":"build-2803163510"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Myasthenia gravis (MG) is an antibody-mediated autoimmune disorder of the neuromuscular junction in which weakness fluctuates across symptom domains, daily activities, and treatment cycles. Established measures such as the Quantitative Myasthenia Gravis score, Myasthenia Gravis Composite, Myasthenia Gravis Activities of Daily Living scale, and MG-specific quality-of-life instruments remain the principal clinical anchors, but intermittent assessments may miss intraday variability, exertional fatigability, and changes across treatment cycles. This structured narrative review examines electronic patient-reported outcomes, smartphone-based active tasks, speech and video analysis, wearable sensing, telemedicine services, prediction models, and candidate digital endpoints. It also distinguishes the validation requirements of these modalities and critically appraises the MG-specific evidence. Most published studies demonstrate feasibility, adherence, acquisition reliability, or preliminary construct validity; most are small, short, and incompletely stratified by antibody subtype, and independent external validation and impact studies remain uncommon. Accordingly, subtype-specific digital trajectories should be regarded as a research hypothesis rather than as an established feature of AChR-, MuSK-, LRP4-associated, or seronegative MG. We present an MG digital phenotype and a five-stage closed-loop workflow as organizing frameworks, not as consensus standards or validated care pathways. Near-term value is most plausible in structured remote follow-up, treatment-cycle characterization, and exploratory trial measurement, provided that outputs remain domain-specific, respiratory safety is protected, and abnormal signals undergo human clinical review.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1948530","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:02:07Z","timestamp":1788444127000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Digital assessment in myasthenia gravis: evidence, validation, and a proposed framework for autoimmune heterogeneity, remote monitoring, and clinical endpoints"],"prefix":"10.3389","volume":"17","author":[{"given":"Mengyi","family":"Wang","sequence":"first","affiliation":[{"name":"The First Clinical College, Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanpeng","family":"Huang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Chai","sequence":"additional","affiliation":[{"name":"The First Clinical College, Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqing","family":"Li","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Qiao","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Xie","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI179742","article-title":"Myasthenia gravis: the future is here","volume":"134","author":"Kaminski","year":"2024","journal-title":"J Clin Invest"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1404191","article-title":"Targeting autoimmune mechanisms by precision medicine in myasthenia gravis","volume":"15","author":"Cavalcante","year":"2024","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2024.104468","article-title":"275th ENMC international workshop: seronegative myasthenia gravis: an update paradigm for diagnosis and management, 9\u201311 February 2024, Hoofddorp, the Netherlands","volume":"44","author":"Evoli","year":"2024","journal-title":"Neuromuscul Disord"},{"key":"B4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/B978-0-12-823912-4.00026-8","article-title":"Myasthenia gravis: pathophysiology, diagnosis, and treatment","volume":"200","author":"Tannemaat","year":"2024","journal-title":"Handb Clin Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mus.27832","article-title":"Myasthenic crisis","volume":"68","author":"Claytor","year":"2023","journal-title":"Muscle Nerve"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16463","article-title":"Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravis","volume":"32","author":"Reyes-Leiva","year":"2025","journal-title":"Eur J Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-066445","article-title":"Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG","volume":"13","author":"Dewilde","year":"2023","journal-title":"BMJ Open"},{"key":"B8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/22143602241296314","article-title":"The telemedical platform MyaLink for remote monitoring in myasthenia gravis: rationale and protocol for a proof of concept study","volume":"13","author":"Stein","year":"2026","journal-title":"J Neuromuscul Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-021-00285-w","article-title":"The lived experience of myasthenia gravis: a patient-led analysis","volume":"10","author":"Law","year":"2021","journal-title":"Neurol Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.70257","article-title":"Prediction of myasthenia gravis worsening: a machine learning algorithm using wearables and patient-reported measures","volume":"13","author":"Stein","year":"2026","journal-title":"Ann Clin Transl Neurol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.596382","article-title":"Outcome measures in clinical trials of patients with myasthenia gravis","volume":"11","author":"Thomsen","year":"2020","journal-title":"Front Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207278","article-title":"Addressing outcome measure variability in myasthenia gravis clinical trials","volume":"101","author":"Guptill","year":"2023","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181dc1b1e","article-title":"The MG Composite: a valid and reliable outcome measure for myasthenia gravis","volume":"74","author":"Burns","year":"2010","journal-title":"Neurology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25198","article-title":"International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r","volume":"54","author":"Burns","year":"2016","journal-title":"Muscle Nerve"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11517-w","article-title":"Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT)","volume":"270","author":"Sacc\u00e0","year":"2023","journal-title":"J Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2196\/58266","article-title":"App- and wearable-based remote monitoring for patients with myasthenia gravis and its specialists: feasibility and usability study","volume":"9","author":"Stein","year":"2025","journal-title":"JMIR Form Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000549122","article-title":"Development and feasibility assessment of a multimodal digital health technology for remote monitoring of symptoms in myasthenia gravis","volume":"9","author":"Mishra","year":"2025","journal-title":"Digit biomark"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.70293","article-title":"Remote monitoring in myasthenia gravis: exploring symptom variability","volume":"13","author":"Stein","year":"2026","journal-title":"Ann Clin Transl Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-026-00932-0","article-title":"Digital monitoring of patients with generalized myasthenia gravis: a prospective pilot study","volume":"15","author":"Vesperinas","year":"2026","journal-title":"Neurol Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16180","article-title":"Refocusing generalized myasthenia gravis: patient burden, disease profiles, and the role of evolving therapy","volume":"31","author":"Sacc\u00e0","year":"2024","journal-title":"Eur J Neurol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2024.0044","article-title":"Batoclimab vs placebo for generalized myasthenia gravis: a randomized clinical trial","volume":"81","author":"Yan","year":"2024","journal-title":"JAMA Neurol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.70051","article-title":"ADAPT NXT: fixed cycles or every-other-week IV efgartigimod in generalized myasthenia gravis","volume":"12","author":"Habib","year":"2025","journal-title":"Ann Clin Transl Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2100066","article-title":"Terminal complement inhibitor ravulizumab in generalized myasthenia gravis","volume":"1","author":"Vu","year":"2022","journal-title":"NEJM Evid"},{"key":"B24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00415-025-12958-9","article-title":"Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia gravis: the randomized open-label extension MG0004 study","volume":"272","author":"Bril","year":"2025","journal-title":"J Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2501561","article-title":"A phase 3 trial of inebilizumab in generalized myasthenia gravis","volume":"392","author":"Nowak","year":"2025","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65792","article-title":"Characterizing myasthenia gravis symptoms, exacerbations, and crises from neurologist's clinical notes using natural language processing","volume":"16","author":"Darer","year":"2024","journal-title":"Cureus"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1474884","article-title":"Application of digital tools and artificial intelligence in the myasthenia gravis core examination","volume":"15","author":"Garbey","year":"2024","journal-title":"Front Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000531224","article-title":"Development and assessment of an artificial intelligence-based tool for ptosis measurement in adult myasthenia gravis patients using selfie video clips recorded on smartphones","volume":"7","author":"Lootus","year":"2023","journal-title":"Digit biomark"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2196\/54518","article-title":"Key considerations for designing clinical studies to evaluate digital health solutions","volume":"26","author":"Bolinger","year":"2024","journal-title":"J Med Internet Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00544-y","article-title":"Experience of daily life with generalized myasthenia gravis: a qualitative investigation and assessment of instrument content validity","volume":"12","author":"Hartford","year":"2023","journal-title":"Neurol Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12883-024-03553-y","article-title":"Systematic review of the patient burden of generalised myasthenia gravis in Europe, the Middle East, and Africa","volume":"24","author":"McCallion","year":"2024","journal-title":"BMC Neurol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2196\/46992","article-title":"Digital health technology for real-world clinical outcome measurement using patient-generated data: systematic scoping review","volume":"25","author":"Pyper","year":"2023","journal-title":"J Med Internet Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41746-020-0260-4","article-title":"Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for biometric monitoring technologies (BioMeTs)","volume":"3","author":"Goldsack","year":"2020","journal-title":"NPJ Digit Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41746-024-01322-2","article-title":"V3+ extends the V3 framework to ensure user-centricity and scalability of sensor-based digital health technologies","volume":"8","author":"Bakker","year":"2025","journal-title":"NPJ Digit Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2196\/58035","article-title":"Digital health readiness: making digital health care more inclusive","volume":"12","author":"Bober","year":"2024","journal-title":"JMIR Mhealth Uhealth"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27476","article-title":"Utilization of MG-ADL in myasthenia gravis clinical research and care","volume":"65","author":"Muppidi","year":"2022","journal-title":"Muscle Nerve"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002971","article-title":"Development and validation of the myasthenia gravis impairment index","volume":"87","author":"Barnett","year":"2016","journal-title":"Neurology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1502721","article-title":"Cutoffs on severity metrics for minimal manifestations or better status in patients with generalized myasthenia gravis","volume":"15","author":"Watanabe","year":"2024","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/mus.28417","article-title":"Standardization of myasthenia gravis outcome measures in clinical practice: a report of the MGFA task force","volume":"72","author":"Ruzhansky","year":"2025","journal-title":"Muscle Nerve"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00464-x","article-title":"Measuring overall severity of myasthenia gravis (MG): evidence for the added value of the MG Symptoms PRO","volume":"12","author":"Regnault","year":"2023","journal-title":"Neurol Ther"},{"key":"B41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00415-026-13757-6","article-title":"Assessing respiratory status in myasthenia gravis: limited value of the MG-ADL as a standalone tool compared with spirometry in a Danish cohort","volume":"273","author":"Andersen","year":"2026","journal-title":"J Neurol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000502000","article-title":"Traditional and digital biomarkers: two worlds apart","volume":"3","author":"Babrak","year":"2019","journal-title":"Digit biomark"},{"key":"B43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048198","article-title":"Patient-reported impact of myasthenia gravis in the real world: protocol for a digital observational study (MyRealWorld MG)","volume":"11","author":"Berrih-Aknin","year":"2021","journal-title":"BMJ Open"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1144183","article-title":"A decentralized, prospective, observational study to collect real-world data from patients with myasthenia gravis using smartphones","volume":"14","author":"Steyaert","year":"2023","journal-title":"Front Neurol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-068104","article-title":"Patient-reported impact of myasthenia gravis in the real world: findings from a digital observational survey-based study (MyRealWorld MG)","volume":"13","author":"Berrih-Aknin","year":"2023","journal-title":"BMJ Open"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2024.123135","article-title":"Psychometric properties of MG-ADL items and MG-ADL score: an assessment of distributional characteristics, validity and factor structure in two large datasets","volume":"463","author":"Janssen","year":"2024","journal-title":"J Neurol Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djae049","article-title":"Effects of a change in recall period on reporting severe symptoms: an analysis of a pragmatic multisite trial","volume":"116","author":"Paudel","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2196\/54120","article-title":"Community-dwelling older adults' readiness for adopting digital health technologies: cross-sectional survey study","volume":"8","author":"Ausserhofer","year":"2024","journal-title":"JMIR Form Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1590\/2317-1782\/20232023055en","article-title":"Did the speech of patients with myasthenia gravis decline over 4 years","volume":"36","author":"Ayres","year":"2023","journal-title":"Codas"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-022-01904-5","article-title":"Comprehensive evaluation of velopharyngeal function in myasthenia gravis patients","volume":"122","author":"Dumbak","year":"2022","journal-title":"Acta Neurol Belg"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2026.1756913","article-title":"Making the invisible audible: a real-world connected speech study in myasthenia gravis","volume":"17","author":"Zangh\u00ec","year":"2026","journal-title":"Front Neurol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3233\/JND-190407","article-title":"Ocular weakness in myasthenia gravis: changes in affected muscles are a distinct clinical feature","volume":"6","author":"de Meel","year":"2019","journal-title":"J Neuromuscul Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51823","article-title":"Assessing facial weakness in myasthenia gravis with facial recognition software and deep learning","volume":"10","author":"Ruiter","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.336330","article-title":"Is video-oculography a predictive test for myasthenia gravis with ocular symptoms","volume":"70","author":"Sirin","year":"2022","journal-title":"Neurol India"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2022.938088","article-title":"Ocular myasthenia gravis saccades as a measure of extraocular muscle function","volume":"2","author":"Wong","year":"2022","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11611-7","article-title":"Oculomotor fatigability with decrements of saccade and smooth pursuit for diagnosis of myasthenia gravis","volume":"270","author":"Nguyen","year":"2023","journal-title":"J Neurol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/mus.70072","article-title":"Building a quantitative telemedicine platform for myasthenia gravis: augmenting the physical examination","volume":"73","author":"Garbey","year":"2026","journal-title":"Muscle Nerve"},{"key":"B59","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/mus.70234","article-title":"Digital phenotyping and lifestyle intervention in patients with myasthenia gravis (DIG-MG): a randomized controlled trial of feasibility, adherence, and effects on fatigue","volume":"74","author":"Norling","year":"2026","journal-title":"Muscle Nerve"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3233\/JND-210637","article-title":"Free-living physical activity and sedentary behaviour in autoimmune myasthenia gravis: a cross-sectional study","volume":"8","author":"Birnbaum","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/mus.28282","article-title":"Longitudinal relationships between free-living activities, fatigue, and symptom severity in myasthenia gravis using cohort and individualized models","volume":"71","author":"Dimmick","year":"2025","journal-title":"Muscle Nerve"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3233\/JND-210693","article-title":"Habitual physical activity in patients with myasthenia gravis assessed by accelerometry and questionnaire","volume":"9","author":"Andersen","year":"2022","journal-title":"J Neuromuscul Dis"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2025.108726","article-title":"Sleep disorders in myasthenia gravis: a systematic review on prevalence, clinical associations, and the accuracy of assessment methodologies","volume":"138","author":"Yakubu","year":"2026","journal-title":"Sleep Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.nmd.2024.06.003","article-title":"Reliability and validity of cough peak flow measurements in myasthenia gravis","volume":"41","author":"Kuroiwa","year":"2024","journal-title":"Neuromuscul Disord"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nmd.2024.05.005","article-title":"Office-based respiratory assessment in patients with generalized myasthenia gravis","volume":"40","author":"Alcantara","year":"2024","journal-title":"Neuromuscul Disord"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27260","article-title":"Telemedicine visits in myasthenia gravis: expert guidance and the Myasthenia Gravis Core Exam (MG-CE)","volume":"64","author":"Guidon","year":"2021","journal-title":"Muscle Nerve"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1109\/TNSRE.2024.3435042","article-title":"Wearable technologies for monitoring upper extremity functions during daily life in neurologically impaired individuals","volume":"32","author":"Proietti","year":"2024","journal-title":"IEEE Trans Neural Syst Rehabil Eng"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s10916-025-02335-4","article-title":"Evaluating AI research quality in myasthenia gravis: a longitudinal study using the CLARITY Framework (2020-2024)","volume":"50","author":"Marconi","year":"2026","journal-title":"J Med Syst"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2025.105970","article-title":"Show and tell: a critical review on robustness and uncertainty for a more responsible medical AI","volume":"202","author":"Marconi","year":"2025","journal-title":"Int J Med Inform"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081554","article-title":"FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare","volume":"388","author":"Lekadir","year":"2025","journal-title":"BMJ"},{"key":"B71","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41746-023-00832-9","article-title":"Perspectives on validation of clinical predictive algorithms","volume":"6","author":"de Hond","year":"2023","journal-title":"NPJ Digit Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2008.00470.x","article-title":"Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome measures: ISPOR ePRO Good Research Practices Task Force report","volume":"12","author":"Coons","year":"2009","journal-title":"Value Health"},{"key":"B73","volume-title":"Patient-focused drug development: selecting, developing, or modifying fit-for-purpose clinical outcome assessments. Guidance for industry, FDA staff, and other stakeholders","year":"2025"},{"key":"B74","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000531054","article-title":"Clinical validation of novel digital measures: statistical methods for reliability evaluation","volume":"7","author":"Ratitch","year":"2023","journal-title":"Digit biomark"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-025-00794-y","article-title":"Considerations and approaches to establishing estimates of meaningful change for digital endpoints as drug development tools","volume":"59","author":"Carthy","year":"2025","journal-title":"Ther Innov Regul Sci"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/bios11100350","article-title":"Mitigation of data packet loss in Bluetooth Low Energy-based wearable healthcare ecosystem","volume":"11","author":"Tipparaju","year":"2021","journal-title":"Biosens-Basel"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1186\/s44247-024-00062-3","article-title":"NiMBaLWear analytics pipeline for wearable sensors: a modular, open-source platform for evaluating multiple domains of health and behaviour","volume":"2","author":"Beyer","year":"2024","journal-title":"BMC Digit Health"},{"key":"B78","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41746-020-0226-6","article-title":"Investigating sources of inaccuracy in wearable optical heart rate sensors","volume":"3","author":"Bent","year":"2020","journal-title":"NPJ Digit Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.2196\/58956","article-title":"A hierarchical framework for selecting reference measures for the analytical validation of sensor-based digital health technologies","volume":"27","author":"Bakker","year":"2025","journal-title":"J Med Internet Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-074820","article-title":"Evaluation of clinical prediction models (part 2): how to undertake an external validation study","volume":"384","author":"Riley","year":"2024","journal-title":"BMJ"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01981-2","article-title":"Multimodal biomedical AI","volume":"28","author":"Acosta","year":"2022","journal-title":"Nat Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s11263-024-02032-8","article-title":"Multimodal machine learning in image-based and clinical biomedicine: survey and prospects","volume":"132","author":"Warner","year":"2024","journal-title":"Int J Comput Vis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocab017","article-title":"The impact of electronic health record-integrated patient-generated health data on clinician burnout","volume":"28","author":"Ye","year":"2021","journal-title":"J Am Med Inform Assoc"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1177\/20552076251380054","article-title":"Empowering patients: a multimodal digital health technology survey of patients with neurogenerative disorders and immune-mediated inflammatory diseases","volume":"11","author":"Maetzler","year":"2025","journal-title":"Digit Health"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.2196\/45166","article-title":"Operational implementation of remote patient monitoring within a large ambulatory health system: multimethod qualitative case study","volume":"10","author":"Lawrence","year":"2023","journal-title":"JMIR Hum Factors"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.2196\/19769","article-title":"A simulated graphical interface for integrating patient-generated health data from smartwatches with electronic health records: usability study","volume":"7","author":"Alpert","year":"2020","journal-title":"JMIR Hum Factors"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/23.022","article-title":"Benefits and challenges of remote patient monitoring as perceived by health care practitioners: a systematic review","volume":"27","author":"Serrano","year":"2023","journal-title":"Perm J"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocaa177","article-title":"Remote symptom monitoring integrated into electronic health records: a systematic review","volume":"27","author":"Gandrup","year":"2020","journal-title":"J Am Med Inform Assoc"},{"key":"B90","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41746-025-01513-5","article-title":"Regulatory considerations for successful implementation of digital endpoints in clinical trials for drug development","volume":"8","author":"Erdemli","year":"2025","journal-title":"NPJ Digit Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2021.106661","article-title":"Considerations to address missing data when deriving clinical trial endpoints from digital health technologies","volume":"113","author":"Di","year":"2022","journal-title":"Contemp Clin Trials"},{"key":"B92","volume-title":"Digital health technologies for remote data acquisition in clinical investigations: guidance for industry, investigators, and other stakeholders","year":"2023"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0000022","article-title":"Sources of bias in artificial intelligence that perpetuate healthcare disparities: a global review","volume":"1","author":"Celi","year":"2022","journal-title":"PloS Digit Health"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(24)00224-3","article-title":"Tackling algorithmic bias and promoting transparency in health datasets: the STANDING Together consensus recommendations","volume":"7","author":"Alderman","year":"2025","journal-title":"Lancet Digit Health"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(22)00234-5","article-title":"Does deidentification of data from wearable devices give us a false sense of security? a systematic review","volume":"5","author":"Chikwetu","year":"2023","journal-title":"Lancet Digit Health"},{"key":"B96","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12910-022-00849-x","article-title":"Electronic informed consent criteria for research ethics review: a scoping review","volume":"23","author":"Yusof","year":"2022","journal-title":"BMC Med Ethics"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1177\/20552076231153740","article-title":"Ethical considerations for the use of consumer wearables in health research","volume":"9","author":"Sui","year":"2023","journal-title":"Digit Health"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-022-05918-y","article-title":"Development and validation of the myasthenia gravis telescore (MGTS)","volume":"43","author":"Pasqualin","year":"2022","journal-title":"Neurol Sci"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01726-y","article-title":"Pharmacotherapy of generalized myasthenia gravis with special emphasis on newer biologicals","volume":"82","author":"Menon","year":"2022","journal-title":"Drugs"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21923","article-title":"Clinical experience with maintenance therapeutic plasma exchange in refractory generalized myasthenia gravis","volume":"36","author":"Sheckley","year":"2021","journal-title":"J Clin Apher"},{"key":"B101","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/mus.28289","article-title":"Efficacy and safety of maintenance intravenous immunoglobulin in generalized myasthenia gravis patients with acetylcholine receptor antibodies: A multicenter, double-blind, placebo-controlled trial","volume":"71","author":"Bril","year":"2025","journal-title":"Muscle Nerve"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.70230","article-title":"Design of and early insights from a generalized myasthenia gravis patient engagement research council","volume":"7","author":"Geonnotti","year":"2024","journal-title":"Health Sci Rep"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2024.0280","article-title":"Escalation pathways of remote patient monitoring programs for COVID-19 patients in Canada and the United States: A rapid review","volume":"31","author":"Hicks","year":"2025","journal-title":"Telemed J E Health"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1126\/science.adq4994","article-title":"The value of decentralized clinical trials: Inclusion, accessibility, and innovation","volume":"385","author":"Jean-Louis","year":"2024","journal-title":"Science"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3192","article-title":"Tepid uptake of digital health technologies in clinical trials by pharmaceutical and medical device firms","volume":"115","author":"Marra","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.2196\/50421","article-title":"Patient and public willingness to share personal health data for third-party or secondary uses: Systematic review","volume":"26","author":"Baines","year":"2024","journal-title":"J Med Internet Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(23)00156-5","article-title":"Federated electronic health records for the European Health Data Space","volume":"5","author":"Raab","year":"2023","journal-title":"Lancet Digit Health"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.2671","article-title":"Assessing telemedicine unreadiness among older adults in the United States during the COVID-19 pandemic","volume":"180","author":"Lam","year":"2020","journal-title":"JAMA Intern Med"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2024.03.009","article-title":"Demystifying the digital divide: Disparities in telerehabilitation readiness among older adults in the United States","volume":"105","author":"Falvey","year":"2024","journal-title":"Arch Phys Med Rehabil"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2024.1408170","article-title":"Provision of digital devices and internet connectivity to improve synchronous telemedicine access in the U.S.: a systematic scoping review","volume":"6","author":"Bell","year":"2024","journal-title":"Front Digit Health"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad123","article-title":"2023 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on practical management of the remote device clinic","volume":"25","author":"Ferrick","year":"2023","journal-title":"Europace"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocae006","article-title":"A national survey of digital health company experiences with electronic health record application programming interfaces","volume":"31","author":"Barker","year":"2024","journal-title":"J Am Med Inform Assoc"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-023-08557-x","article-title":"Challenges and facilitators in implementing remote patient monitoring programs in primary care","volume":"39","author":"Hailu","year":"2024","journal-title":"J Gen Intern Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41746-021-00421-8","article-title":"Need for clarifying remote physiologic monitoring reimbursement during the COVID-19 pandemic: a respiratory disease case study","volume":"4","author":"Jarrin","year":"2021","journal-title":"NPJ Digit Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1055\/s-0041-1741495","article-title":"Digital phenotyping in clinical neurology","volume":"42","author":"Gupta","year":"2022","journal-title":"Semin Neurol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41746-021-00521-5","article-title":"Digital medicine and the curse of dimensionality","volume":"4","author":"Berisha","year":"2021","journal-title":"NPJ Digit Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27822","article-title":"Clinical characteristics of anti-AChR-MuSK-LRP4 antibody-negative myasthenia gravis in China","volume":"67","author":"Li","year":"2023","journal-title":"Muscle Nerve"},{"key":"B118","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41746-023-00928-2","article-title":"Does clinical research account for diversity in deploying digital health technologies","volume":"6","author":"Coss","year":"2023","journal-title":"NPJ Digit Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1948530\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:02:09Z","timestamp":1788444129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1948530\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":118,"alternative-id":["10.3389\/fimmu.2026.1948530"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1948530","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1948530"}}